Intrexon Corporation (NYSE: XON) announced today it has commenced an underwritten public offering of shares of its common stock. In addition, Intrexon intends to grant the underwriters a 30-day option to purchase additional shares of its common stock. The offering is subject to market and other conditions and there can be no assurances as to whether or when the offering may be completed, or as to the size or terms of the offering.
JMP Securities LLC is acting as sole book-running manager for the offering.
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet. Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.